BCL2 and nasopharyngeal carcinoma: Using IHC, BCL-2 expression was detected in 80% NPC tissues and 71% adjacent dysplastic lesions compared to only 37% in nasopharynx epithelial (NPE) and 30% in NPE of chronically inflamed nasopharynx patients [4].